
Novo Nordisk’s growth spurt in Kalundborg, Denmark, is ostensibly still ongoing.
A number of Danish media, including SN.dk, are reporting that the firm is investing DKK 1bn (USD 143.8m) in building one new factory and upgrading two production facilities in the Danish city.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app